NewGenIvf Group (NIVF) Q4 2025 Earnings
NIVF·Reported April 1, 2026
NewGenIvf Group reported Q4 2025 revenue of $2.7M (+112.4% YoY), missed analyst consensus of $2.9M by $166.0K. Diluted EPS came in at $-2.02 (-112.9% YoY), missed the $46.35 consensus by $48.37.
Revenue
$2.7Mmissed by $166.0K
Consensus: $2.9MDiluted EPS
$-2.02missed by $48.37
Consensus: $46.35
SEC Filings
Earnings release8-K not filed yet
Quarterly report10-Q / 10-K not filed yet
Filings will appear here once submitted to SEC EDGAR.
Q4 2025 Earnings FAQ
Common questions about NewGenIvf Group's Q4 2025 earnings report.
NewGenIvf Group (NIVF) reported Q4 2025 earnings on April 1, 2026.
NewGenIvf Group reported revenue of $2.7M and diluted EPS of $-2.02 for Q4 2025.
Revenue missed the consensus estimate of $2.9M by $166.0K. EPS missed the consensus estimate of $46.35 by $48.37.
Compared to the same quarter a year prior, revenue grew 112.4% from $1.3M a year earlier and diluted EPS declined 112.9% from $-0.95.